Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Eisai Co., Ltd.

Capitalization 1,073B 6.7B 5.8B 5.34B 5.01B 9.33B 640B 9.49B 62.51B 24.54B 309B 25.15B 24.6B P/E ratio 2026
35.6x
P/E ratio 2027 * 19.2x
Enterprise value 956B 5.97B 5.17B 4.75B 4.47B 8.31B 570B 8.45B 55.68B 21.86B 275B 22.4B 21.92B EV / Sales 2026
1.59x
EV / Sales 2027 * 1.08x
Free-Float
90.73%
Yield 2026
3.28%
Yield 2027 * 4.21%
1 day-1.55%
1 week-1.86%
Current month-5.95%
1 month-19.35%
3 months-22.28%
6 months-20.09%
Current year-19.59%
1 week 3,719
Extreme 3719
3,866
1 month 3,719
Extreme 3719
4,748
Current year 3,719
Extreme 3719
5,243
1 year 3,719
Extreme 3719
5,349
3 years 3,463
Extreme 3463
11,250
5 years 3,463
Extreme 3463
12,765
10 years 3,463
Extreme 3463
12,765
Manager TitleAgeSince
Chief Executive Officer 78 31/05/2003
Director of Finance/CFO 48 31/12/2025
Chief Tech/Sci/R&D Officer 47 31/03/2025
Director TitleAgeSince
Director/Board Member 78 31/05/1983
Director/Board Member 66 13/06/2024
Director/Board Member 67 31/05/2025
Change 5d. change 1-year change 3-years change Capi.($)
-1.58%-1.86%-5.95%-64.62% 6.69B
+1.57%+6.19%+49.26%+157.85% 1,025B
-0.26%+3.87%+49.75%+44.86% 559B
-1.83%+4.76%+17.51%+62.07% 394B
+0.77%+3.06%+21.96%+15.20% 324B
-1.05%+3.78%+51.35%+8.34% 295B
-0.45%+2.69%+27.95%+17.41% 286B
-0.54%+3.02%+20.87%+29.84% 270B
-4.17%-4.53%-44.53%-50.50% 186B
-1.10%+5.04%+19.08%+56.61% 187B
Average -0.86%+2.78%+20.73%+27.71% 353.29B
Weighted average by Cap. -0.17%+4.01%+32.93%+65.80%

Financials

2026 2027 *
Net sales 817B 5.1B 4.42B 4.06B 3.82B 7.11B 488B 7.23B 47.6B 18.69B 235B 19.15B 18.74B 890B 5.56B 4.81B 4.43B 4.16B 7.74B 531B 7.87B 51.86B 20.36B 256B 20.87B 20.41B
Net income 45.54B 284M 246M 227M 213M 396M 27.18B 403M 2.65B 1.04B 13.12B 1.07B 1.04B 56.27B 351M 304M 280M 263M 489M 33.58B 498M 3.28B 1.29B 16.21B 1.32B 1.29B
Net Debt -117B -732M -634M -583M -548M -1.02B -69.93B -1.04B -6.83B -2.68B -33.76B -2.75B -2.69B -111B -694M -601M -553M -520M -967M -66.36B -983M -6.48B -2.54B -32.03B -2.61B -2.55B
Logo Eisai Co., Ltd.
Eisai Co Ltd is a Japan-based pharmaceutical company mainly engaged in the research and development, manufacture, sale, import and export of pharmaceuticals. The Company operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The segment operates in five regions including Japan, Americas (North America), China, EMEA (Europe, Middle East, Africa, Russia, Oceania), Asia and Latin America (Korea, Taiwan, India, ASEAN, Latin America). The Others segment is involved in license revenues and pharmaceutical raw materials business. The Company is also engaged in the provision of brands such as the anticancer drugs Lembima and Halaven on the nerve and oncology areas.
Employees
10,917
Date Price Change Volume
09/06/26 3,746.00 ¥ -1.58% 1,132,300
08/06/26 3,806.00 ¥ +0.82% 1,696,200
05/06/26 3,775.00 ¥ -1.05% 1,769,400
04/06/26 3,815.00 ¥ +1.49% 1,753,400
03/06/26 3,759.00 ¥ -1.55% 2,179,400
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
3,806.00JPY
Average target price
4,607.69JPY
Spread / Average Target
+21.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4523 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
BENEFIT NOW